Skip to main content
padlock icon - secure page this page is secure

Primary central nervous system posttransplantation lymphoproliferative disorder after heart and lung transplantation

Buy Article:

$47.00 + tax (Refund Policy)

Primary central nervous system posttransplantation lymphoproliferative disorder (PCNS‐PTLD) is uncommon, especially after heart or lung transplantation. Database analysis from a single heart and lung transplantation centre and a literature review pertaining to PCNS‐PTLD was performed. In this study, the prevalence of PCNS‐PTLD was 0.18% after heart and/or lung transplants. Of 1674 transplants, three cases of PCNS‐PTLD developed 14 months, 9 years and 17 years posttransplant, and all were Epstein–Barr virus driven malignancies. Literature review of the topic revealed predominantly retrospective studies, with most reported cases after renal transplantation. The overall survival is poor, and it may be improved by early diagnosis and treatment. There are no published guidelines on the management of PCNS‐PTLD; immune‐chemotherapy in conjunction with reduction of immune suppression is preferred based on available evidence.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: central nervous system; heart; lung; lymphoma; posttransplant lymhpoproliferative disorder; transplantation

Document Type: Research Article

Publication date: May 1, 2015

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more